They should get some press coverage in the USA tonight re the start of the Hep C trial. The NASDAQ punters are very bio tech savvy and the Hep C fix is potentially worth anything.
BLT Price at posting:
$1.22 Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
